Efficacy and tolerance of cotrimoxazole for the treatment of toxoplasmic encephalitis in AIDS patients;Efficacite et bonne tolerance du cotrimoxazole comme traitement de la toxoplasmose cerebrale au cours du SIDA

Presse Medicale

Volumn 27, Issue 26, 1998, Pages 1315-1320

  Smadja, D ^a   Fournerie, P ^a   Cabre, P ^a   Cabie, A ^a   Olindo, S ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; PYRIMETHAMINE; SULFADIAZINE; ANTIINFECTIVE AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; ENCEPHALITIS; HUMAN; OPPORTUNISTIC INFECTION; PATIENT COMPLIANCE; PROSPECTIVE STUDY; TOXOPLASMA; ADOLESCENT; AIDS RELATED COMPLEX; CLINICAL TRIAL; DRUG ADMINISTRATION; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; PARASITOLOGY; PATIENT SELECTION; RADIOGRAPHY; RECURRENT DISEASE; TOXOPLASMOSIS;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; RECURRENCE; TOMOGRAPHY, X-RAY COMPUTED; TOXOPLASMOSIS, CEREBRAL; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0032511477     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Leport C, Raffi F, Matheron S et al. Treatment of Central Nervous System Toxoplasmosis with pyremethamine/ sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy. Am J Med 1988 ; 84:94-100.
2. Porter S, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1992 ; 327:1643-8.
3. Cohn JA, McMeeking A, Cohen W, Jacobs J, Holzman RS. Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome. Am J Med 1989 ; 86:521-7.
4. Haverkos HW. Assement of therapy for toxoplasma encephalitis. The TE study Group. Am J Med 1987 ; 82:907-14.
5. Katlama C, De Wit S, O'Doherty E, Van Glabecke M, Clumek L. Pyremethamine-Clindamycin vs Pyremethamine-Sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis 1996 ; 22:268-75.
6. Nguyen BT, Stadtsbaeder S. In vitro activity of cotrimoxazole on the intracellular multiplication of Toxoplasma gondii. Path Eur 1975 ; 10:307-15.
7. Carr A, Tindall B, Brew BJ et al. Low-dose Trimethoprim-Sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1992 ; 117:106-11.
8. Podzamczer D, Santin M, Jimenez J et al. Thrice-weekly cotrimoxazole is better than dapsone-pyrimethamine for the primary prevention of Pneumocystis carinii pneumonia in HIV-infected patients. AIDS 1993 ; 7:501-6.
9. Behbahani R, Moshfeghy M, Baxter JD. Therapeutic approaches for AIDS-related toxoplasmosis. Ann Pharmacother 1995 ; 29:760-8.
10. Opremcak EM, Scales DK, Sharpe MR. Trimethoprim-Sulfamethoxazole therapy for ocular toxoplasmosis. Ophthalmology 1992 ; 99:920-5.
11. Solbreux P, Sonnet J, Zech F. A retrospective study about the use of Cotrimoxazole as diagnostic support and treatment of suspected cerebral toxoplasmosis in AIDS. Acta Clin Belg 1990 ; 45:85-96.
12. Canessa A, Del Bono V, De Leo P, Piersantelli N, Terragna A. Cotrimoxazole therapy of Toxoplasma Gondii encephalitis in AIDS patients. Eur J Clin Microbiol Infect Dis 1992 ; 11:125-30.
13. Nobrega JPS. Tratamento da neurotoxoplasmose com a associaçao sulfametoxazol-trimetoprim.Relato de 10 casos. Arq Neuro-Psiquiat (Sao Paulo) 1991 ; 49:279-84.
14. Carosi M. Cotrimoxazole for cerebral toxoplasmosis in AIDS patients (Abstract) International Congress for infectious diseases, Montréal, Canada, July 1990.
15. Menichetti F, Maroni M, Di Candilo F, Fiorio M, Pauluzzi F. Cotrimoxazole for cerebral toxoplasmosis in AIDS (Abstract). In: Program and Abstracts of the Seventh International Conference on AIDS, #WB2311, Florence, Italy; June 1991.
16. Safrin S, Lee BL, Sande MA. Adjunctive folinic add with trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia in AIDS patients is associated with an increase risk of therapeutic failure and death. J Infect Dis 1994 ; 170: 912-17.
17. Bulletin Epidémiologique Hebdomadaire. Surveillance du SIDA en France (situation au 30 juin 1996). 1996 ; 36:155-61.
18. Schneider MM, Nielsen TL, Nelsing S et al. Efficacy and safety of two doses of trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus. Dutch AIDS Treatment Group. J Infect Dis 1995 ; 171:1632-6.
19. Morlat P, Leport C. La prophylaxie de la toxoplasmose chez les patients immunodéprimés. Ann Med Interne 1997 ; 3:235-9.
20. Dupouy-Camet J, Gavinet MF, Paugam A, Toutre-Schaefer C. Mode de contamination, incidence et prévalence de la toxoplasmose. Med Mal Infect 1993 ; 23:139-47.
21. Georgiev VS. Management of toxoplasmosis. Drugs 1994 ; 48:179-88.